Antheia Scores $56 Million Series C
MENLO PARK — Antheia, a pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced it has raised $56 million in Series C financing. The new financing will be used to expand commercialization of Antheia’s first …